A framework for advancing our understanding of cancer-associated fibroblasts
2020 · Nature reviews. Cancer · 3,554 citations
https://doi.org/10.1038/s41568-019-0238-1
D
Douglas T. Fearon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
310
Papers
41.9K
Citations
86
h-index
175
i10-index
Douglas T. Fearon is an academic researcher from Cornell University. The author has contributed to research in topics: Immune Cell Function and Interaction & T-cell and B-cell Immunology & Immunotherapy and Immune Responses. The author has an h-index of 86, co-authored 264 publications.
ORCID: 0000-0003-0612-0495Papers by this author
worksDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
2017 · The Journal of Experimental Medicine · 2,349 citations
https://doi.org/10.1084/jem.20162024
T cell exclusion, immune privilege, and the tumor microenvironment
2015 · Science · 2,324 citations
https://doi.org/10.1126/science.aaa6204
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
2013 · Proceedings of the National Academy of Sciences · 1,919 citations
https://doi.org/10.1073/pnas.1320318110
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
2018 · Science · 1,389 citations
https://doi.org/10.1126/science.aao4227
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
2020 · Nature · 1,148 citations
https://doi.org/10.1038/s41586-020-2229-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat